Glucose Monitoring

The non-invasive glucose monitoring industry has raised billions chasing a physical impossibility. The real tragedy? That money could have made existing CGMs cheaper, smaller, and more reliable for the millions of diabetics who still pay out of pocket for sensors that break. This article explains why the technology is a dead end—and what we should demand instead.